Lung Stent Market Analysis

Lung Stent Market Analysis

Based on product, the tracheal segment held 69% of the lung stents market share in 2022 and is expected to register growth at a notable CAGR from 2023-2032. The growing popularity of tracheal stents can be attributed to several variables, including their accessibility in a variety of sizes, forms, and materials, as well as the decreased risk of surgical complications following stent implantation. Furthermore, the rising usage of tracheal stents in the therapy of big airways and non-malignant diseases is likely to drive the segment development.

In terms of material, the lung stent market from the hybrid segment is set to witness 12% CAGR from 2023-2032. Hybrid lung stents often have a silicone coating or covering over a metal foundation. This combination lowers the risk of mucosal irritation or tissue overgrowth and enables better adaptability to the airway structure. The adoption of hybrid lung stents also alleviates some of the constraints associated with only metal or silicone stents, subsequently contributing to the industry development.

Based on end-use, the lung stent market size from the hospitals’ segment is projected to reach USD 347.2 million by 2032. The segment growth is attributed to the higher availability of enhanced pulmonology facilities with quick diagnoses. Due to the accessibility of cutting-edge equipment and well-equipped facilities, hospitals are performing an increasing number of respiratory treatments. In addition, the economic burden of lung disease treatment in both developed and developing nations will promote the segmental expansion.

North America lung stent market accounted for more than USD 72.9 million in 2022 and is estimated to exhibit robust growth through 2032. This regional market expansion is driven by the rise in hospitalizations for respiratory disorders. For instance, one in seven middle-aged or older Americans suffer from lung problems, according to latest statistics. Furthermore, the increasing focus by significant firms on providing effective treatment options will influence the regional market progression.